Krsnaa Diagnostics Limited (KRSNAA.NS)
INR 910.0
(-0.9%)
INR 910.0
(-0.9%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 4.13 Billion INR | -19.67% |
| 2022 | 4.12 Billion INR | 4.5% |
| 2021 | 3.95 Billion INR | 26.36% |
| 2020 | 3.12 Billion INR | 35.55% |
| 2019 | 2.3 Billion INR | 20.22% |
| 2018 | 1.91 Billion INR | 516.92% |
| 2017 | 311.06 Million INR | -25.97% |
| 2016 | 420.16 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 1.24 Billion INR | 10.54% |
| 2024 Q1 | 604.46 Million INR | -33.97% |
| 2023 Q3 | 1.05 Billion INR | 6.34% |
| 2023 Q4 | 915.4 Million INR | -13.28% |
| 2023 FY | 3.31 Billion INR | -19.67% |
| 2023 Q1 | 944.24 Million INR | -12.19% |
| 2023 Q2 | 992.71 Million INR | 5.13% |
| 2022 Q1 | 1 Billion INR | 5.6% |
| 2022 Q4 | 1.07 Billion INR | 8.72% |
| 2022 FY | 4.12 Billion INR | 4.5% |
| 2022 Q3 | 989.09 Million INR | -6.34% |
| 2022 Q2 | 1.05 Billion INR | 4.67% |
| 2021 Q1 | 1.1 Billion INR | 83.91% |
| 2021 FY | 3.95 Billion INR | 26.36% |
| 2021 Q4 | 955.44 Million INR | 0.87% |
| 2021 Q3 | 947.22 Million INR | 0.05% |
| 2021 Q2 | 946.75 Million INR | -14.1% |
| 2020 FY | 3.12 Billion INR | 35.55% |
| 2020 Q4 | 599.28 Million INR | 0.0% |
| 2019 FY | 2.3 Billion INR | 20.22% |
| 2019 Q4 | 582.88 Million INR | 0.0% |
| 2018 FY | 1.91 Billion INR | 516.92% |
| 2017 FY | 311.06 Million INR | -25.97% |
| 2016 FY | 420.16 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Dr. Lal PathLabs Limited | 14.62 Billion INR | 71.747% |
| Metropolis Healthcare Limited | 5.81 Billion INR | 28.932% |
| Thyrocare Technologies Limited | 2.5 Billion INR | -65.045% |
| Vijaya Diagnostic Centre Limited | 4.82 Billion INR | 14.355% |
| Vimta Labs Limited | 986.72 Million INR | -318.685% |